Cadence Pharmaceuticals' P2P Acquisition

Cadence Pharmaceuticals raised a round of funding on March 19, 2014. Investors include Mallinckrodt.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.…

Articles about Cadence Pharmaceuticals' P2P Acquisition: